Tertatolol

Tertatolol

Tertatolol is a beta blocker used in the treatment of hypertension and angina pectoris. It is a non-selective beta blocker, meaning it blocks both β1 and β2 adrenergic receptors. Tertatolol is not widely used and is not available in many countries.

Pharmacology

Tertatolol is a competitive antagonist at both β1 and β2 adrenergic receptors, which are found in the heart and blood vessels. By blocking these receptors, tertatolol reduces the effects of adrenaline and noradrenaline, leading to a decrease in heart rate and blood pressure. This makes it useful in the treatment of conditions such as hypertension and angina pectoris.

Clinical use

Tertatolol is used in the treatment of hypertension and angina pectoris. It can be used alone or in combination with other antihypertensive drugs. The usual starting dose is 5 mg once daily, which can be increased if necessary. Tertatolol is generally well tolerated, but like all beta blockers, it can cause side effects such as fatigue, cold extremities, and bradycardia.

History

Tertatolol was first synthesized in the 1970s and has been used in clinical practice since the 1980s. It is not widely used and is not available in many countries.

See also

• Beta blocker
• Hypertension
• Angina pectoris

This article is a stub related to pharmacology. You can help WikiMD by expanding it!

This pharmacology related article is a stub. You can help WikiMD by expanding it.